656 related articles for article (PubMed ID: 2482242)
1. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
2. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.
Cottone M; Turri M; Caltagirone M; Maringhini A; Sciarrino E; Virdone R; Fusco G; Orlando A; Marino L; Pagliaro L
Hepatogastroenterology; 1988 Jun; 35(3):101-3. PubMed ID: 2456973
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
4. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
[TBL] [Abstract][Full Text] [Related]
5. A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
Iwamura K
Tokai J Exp Clin Med; 1982 May; 7(3):397-411. PubMed ID: 6181578
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
7. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
8. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
10. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
12. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
[TBL] [Abstract][Full Text] [Related]
13. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
[TBL] [Abstract][Full Text] [Related]
14. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
16. [Hepatocellular carcinoma--its echographic characteristics and diagnostic potentials].
Naumov N; al-Ruaieh A; Krŭstev Z; Maleev A
Vutr Boles; 1986; 25(3):49-55. PubMed ID: 3020809
[TBL] [Abstract][Full Text] [Related]
17. [Variable clinical symptoms of hepatocellular carcinoma].
Struve C; Heusermann U
Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
[TBL] [Abstract][Full Text] [Related]
18. [The significance of the determination of AFP-isoform in the early diagnosis of hepatocellular carcinoma].
Ishizuka H; Arakawa Y; Nakano E
Rinsho Byori; 1992 Dec; 40(12):1265-73. PubMed ID: 1284914
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of hyperechogenic focal lesions of the cirrhotic liver].
Giorgio A; Amoroso P; de Stefano G; Fico P; Tarantino L; Lettieri G; Pierri P; Finelli L; Pierri G
Radiol Med; 1988 Mar; 75(3):173-6. PubMed ID: 2451843
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
Sangiovanni A; Colombo E; Radaelli F; Bortoli A; Bovo G; Casiraghi MA; Ceriani R; Roffi L; Redaelli A; Rossini A; Spinzi G; Minoli G
Am J Gastroenterol; 2001 May; 96(5):1575-80. PubMed ID: 11374702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
